News

News

Emyria’s Managing Director speaks on the obstacles within the industry

Emyria’s Managing Director speaks on the obstacles within the industry

Our Managing Director, Michael Winlo shining a spotlight on obstacles within the industry, why TGA registration must be the ambition for producers and how our team at Emyria are striving to make a difference.

“Clinics and data-backed medicinal cannabis firm Emyria has embarked on a drug-development program of its own. Here, chief executive Dr Michael Winlo tells Cannabiz that TGA registration must be the ambition for producers, and suggests why some may be unwilling to invest in research.”

Read the full Cannabiz article here 

Have Questions?

If you have any question, please feel free to get in touch with us.

Call 1300 436 363Contact